COMPANY

Cajal Therapeutics

Keywords: small molecule Anemia Iron Deficiencies Chronic Kidney Disease

Location: Seattle, WA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

2026-06 Trial start Early phase 1: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults. source ↗

2026-10 (ESTIMATED) · Early phase 1 · A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults. · NCT07577817

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07577817	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.	Early phase 1	Recruiting	2026-06	2026-10 (estimated)